Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and Its Clinical Subtypes

[1]  P. Gregersen,et al.  Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. , 2014, American journal of human genetics.

[2]  S. Bull,et al.  Human leukocyte antigen alleles and susceptibility to psoriatic arthritis. , 2013, Human immunology.

[3]  M. Simpson,et al.  An In-Depth Characterization of the Major Psoriasis Susceptibility Locus Identifies Candidate Susceptibility Alleles within an HLA-C Enhancer Element , 2013, PloS one.

[4]  K. Humphreys,et al.  Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk. , 2013, American journal of human genetics.

[5]  V. Farewell,et al.  The functional MICA-129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA-B and HLA-C. , 2013, Tissue antigens.

[6]  Peter Donnelly,et al.  Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci , 2013, Nature Genetics.

[7]  Buhm Han,et al.  Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[8]  Yusuke Nakamura,et al.  Identification of a Functional Variant in the MICA Promoter Which Regulates MICA Expression and Increases HCV-Related Hepatocellular Carcinoma Risk , 2013, PloS one.

[9]  Soumya Raychaudhuri,et al.  Risk for myasthenia gravis maps to a 151Pro→Ala change in TNIP1 and to human leukocyte antigen‐B*08 , 2012, Annals of neurology.

[10]  M. Weale,et al.  Conditional analysis identifies three novel major histocompatibility complex loci associated with psoriasis. , 2012, Human molecular genetics.

[11]  James T. Elder,et al.  Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity , 2012, Nature Genetics.

[12]  S. Bull,et al.  Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study , 2012, Annals of the rheumatic diseases.

[13]  R. Winchester,et al.  HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. , 2012, Arthritis and rheumatism.

[14]  H. Asakura.  HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease. , 2012, Gastroenterology.

[15]  Robert M. Plenge,et al.  Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis , 2011, Nature Genetics.

[16]  S. Bull,et al.  Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis , 2011, Annals of the rheumatic diseases.

[17]  Matti Pirinen,et al.  Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity , 2012 .

[18]  V. Farewell,et al.  Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. , 2011, Tissue antigens.

[19]  Jack T Stapleton,et al.  The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.

[20]  Christian Gieger,et al.  Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 , 2010, Nature Genetics.

[21]  Christian Gieger,et al.  Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis , 2010, Nature Genetics.

[22]  Matti Pirinen,et al.  A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 , 2010, Nature Genetics.

[23]  Christian Gieger,et al.  Genome-wide association analysis identifies three psoriasis susceptibility loci , 2010, Nature Genetics.

[24]  M. Phipps,et al.  MICA polymorphism: biology and importance in immunity and disease. , 2010, Trends in molecular medicine.

[25]  James T. Elder,et al.  Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis , 2009, PLoS genetics.

[26]  Frank O. Nestle,et al.  Mechanisms of Disease: Psoriasis. , 2009 .

[27]  R. Winchester,et al.  Psoriatic arthritis: from pathogenesis to therapy , 2009, Arthritis research & therapy.

[28]  Pui-Yan Kwok,et al.  Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways , 2008, Nature Genetics.

[29]  James Robinson,et al.  The IMGT/HLA database , 2008, Nucleic Acids Res..

[30]  A. Silman,et al.  Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis , 2007, Annals of the rheumatic diseases.

[31]  J. Todd,et al.  The Type 1 Diabetes Genetics Consortium , 2006, Annals of the New York Academy of Sciences.

[32]  Pardis C Sabeti,et al.  A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC , 2006, Nature Genetics.

[33]  Dafna Gladman,et al.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.

[34]  Stefan Jenisch,et al.  Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. , 2006, American journal of human genetics.

[35]  T. M. Hsu,et al.  Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR , 2005, Human Genetics.

[36]  Sarah Rowland-Jones,et al.  Structures of Three HIV-1 HLA-B*5703-Peptide Complexes and Identification of Related HLAs Potentially Associated with Long-Term Nonprogression12 , 2005, The Journal of Immunology.

[37]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[38]  R. Trembath,et al.  Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus. , 2002, American journal of human genetics.

[39]  E. Christophers.  Psoriasis − epidemiology and clinical spectrum , 2001, Clinical and experimental dermatology.

[40]  H. Nakagawa,et al.  Study of aspartate at residue 9 of HLA-C molecules in Japanese patients with psoriasis vulgaris. , 1996, Journal of dermatological science.

[41]  P. Parham,et al.  Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27 , 1992, The Journal of experimental medicine.